β(2)-Agonists and Acute Respiratory Distress Syndrome

Ítems similars

• Reply: β(2)-Agonists and Acute Respiratory Distress Syndrome
  per: Budinger, G. R. Scott, et al.
  Publicat: (2014)
• Bench-to-bedside review: β(2)-Agonists and the acute respiratory distress syndrome
  per: Perkins, Gavin D, et al.
  Publicat: (2004)
• β(2)-Agonist therapy may contribute to the air pollution and IL-6–associated risk of developing severe asthma with dual-positive T(H)2/T(H)17 cells
  per: Chiarella, Sergio E., et al.
  Publicat: (2014)
• Importance of the Kidney, Vessels, and Heart with Administration of β(2) Adrenergic Receptor Agonists in Patients Susceptible to Acute Respiratory Distress Syndrome
  per: Snyder, Eric M., et al.
  Publicat: (2014)
• Reply: Importance of the Kidney, Vessels, and Heart with Administration of β(2) Adrenergic Receptor Agonists in Patients Susceptible to Acute Respiratory Distress Syndrome
  per:  Thickett, David R., et al.
  Publicat: (2014)